À compter du 1er décembre 2023, l’accès à POEMs et à Essential Evidence Plus ne fera plus partie des avantages offerts aux membres de l’AMC.
Question clinique
How may patients signal their openness to reducing their opioid dose or using other options to treat their chronic pain?
L’Essentiel
Listen for clues that express concern or doubt about the role of opioids, such as "Sometimes it doesn't work," "It makes my brain fuzzy," or "I like to stay in control of me." When patients question the effect of treatment on pain relief or function, worry about safety or side effects, or reflect on the impact of opioids on their identity, they may be open to discussing other treatment options. 2c
Référence
Plan de l'etude: Qualitative
Financement: Government
Cadre: Outpatient (primary care)
Sommaire
Conversations aimed at reducing opioid doses in patients with chronic pain are often fraught, usually because of fears of the inevitable conflict, gamesmanship, and manipulation. But what if patients offered clues that they might be open to dose reduction? To identify and categorize these clues, the authors analyzed recordings of 86 clinic visits of patients with chronic pain who received an average 42.5 mg morphine equivalents per day. Two authors independently listened to all the recordings. They identified 274 instances in these visits when patients offered an assessment of the opioid and 129 of these assessments as clues that express negative or ambivalent opinions toward opioids. Clues were sorted into 5 categories: (1) pain: "[It] helps a little bit with the pain"; (2) function: "If I take two, I can't function"; (3) safety: "If I have to take more I'll be in serious trouble"; (4) side effects: "I don't like it"; and (5) personal identity: "I'm in a constant war with myself when I take pain medication." More than half (53%) the visits included more than one clue from the patient and 21% contained 3 or more clues. Physicians (n = 49) explored these clues less than half (43%) the time. The authors did not report the effect of these clues; that is, whether any physicians offered other options for pain treatment or dose lowering.
Reviewer
Allen F. Shaughnessy, PharmD, MMedEd
Professor of Family Medicine
Tufts University
Boston, MA